Abstract
Coronavirus disease 2019 (COVID‐19) pandemic has challenged healthcare systems around the world. Unfortunately, failure has become evident with the collapse of high‐income countries where excellent‐quality and efficient systems—with enough resources and advanced scientific technology to establish strong public health strategies based on mathematical models adjusted to serve COVID‐191—have undergone significant strain.
Currently, there are no effective pharmacological interventions with sufficient scientific evidence to treat COVID‐19. Fueled by the epidemiological and clinical impact of its rapid spread, and the alarming fatality rates of over 10% in some countries, the need for in‐hospital management—especially in intensive care units (ICU)—geared public health attention towards previous pharmacological experiences evaluated in other coronavirus strains.
Currently, there are no effective pharmacological interventions with sufficient scientific evidence to treat COVID‐19. Fueled by the epidemiological and clinical impact of its rapid spread, and the alarming fatality rates of over 10% in some countries, the need for in‐hospital management—especially in intensive care units (ICU)—geared public health attention towards previous pharmacological experiences evaluated in other coronavirus strains.
| Translated title of the contribution | Posibles efectos negativos del uso gratuito de cloroquina para el manejo de COVID-19 en Colombia |
|---|---|
| Original language | English (US) |
| Pages (from-to) | 2254-2256 |
| Number of pages | 2 |
| Journal | Journal of Medical Virology |
| Volume | 92 |
| Issue number | 11 |
| DOIs |
|
| State | Accepted/In press - May 26 2020 |
All Science Journal Classification (ASJC) codes
- Virology
- Infectious Diseases
UN SDGs
This output contributes to the following Sustainable Development Goal(s)
